NL
NL · NL · NL-d985fefe2240
Bortezomib Fresenius Kabi 3,5 mg poeder voor oplossing voor injectie.
ATC L01XG01
Last synced from CBG-MEB (Netherlands) on
Identification
ManufacturerFresenius Kabi Deutschland GmbH
CountryNL (NL)
ATC codeL01XG01
Dispensing—
ReimbursedNo
SourceCBG-MEB (Netherlands)
Last synced6/9/2026
Packs · 1
- cbg_meb_idEU/1/19/1397
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Poeder voor oplossing voor injectie",
"route": "Intraveneus gebruik, Subcutaan gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/bortezomib-fresenius-kabi-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Bortezomib",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp123816",
"excipients": [
"MANNITOL (D-) (E 421)",
"STIKSTOF (HEAD SPACE) (E 941)"
],
"substances": [
"BORTEZOMIB"
],
"leaflet_url": null,
"authorised_at": "2019/11/15",
"procedure_number": "EMEA/H/C/005074",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/19/1397",
"additional_monitoring": "N"
}Related drugs
Other records sharing ATC code L01XG01.
Access this data programmatically
Query Bortezomib Fresenius Kabi 3,5 mg poeder voor oplossing voor injectie. and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.